Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population
- PMID: 32801014
- PMCID: PMC7878579
- DOI: 10.1016/j.cgh.2020.08.012
Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population
Abstract
Background & aims: Despite apparent differences between men and women in the prevalence and incidence of nonalcoholic fatty liver disease (NAFLD), there are limited epidemiologic data regarding the associations of reproductive and hormone-related factors with NAFLD. We examined the associations of these factors and exogenous hormone use with NAFLD risk in African American, Japanese American, Latino, Native Hawaiian, and white women.
Methods: We conducted a nested case-control study (1861 cases and 17,664 controls) in the Multiethnic Cohort Study. NAFLD cases were identified using Medicare claims data; controls were selected among participants without liver disease and individually matched to cases by birth year, ethnicity, and length of Medicare enrollment. Reproductive and hormone-related factors and covariates were obtained from the baseline questionnaire. Multivariable logistic regression was used to calculate odds ratios (ORs) and 95% CIs.
Results: Later age at menarche was associated inversely with NAFLD (Ptrend = .01). Parity, regardless of number of children or age at first birth, was associated with increased risk of NAFLD (OR, 1.25; 95% CI, 1.05-1.48). Oral contraceptive use also was linked to increased risk of NAFLD (OR, 1.14; 95% CI, 1.01-1.29; duration of use Ptrend = .04). Compared with women with natural menopause, those with oophorectomy (OR, 1.41; 95% CI, 1.18-1.68) or hysterectomy (OR, 1.33; 95% CI, 1.11-1.60) had an increased risk of NAFLD. A longer duration of menopause hormone therapy (only estrogen therapy) was linked with an increasing risk of NAFLD (OR per 5 years of use, 1.08, 95% CI, 1.01-1.15).
Conclusions: Findings from a large multiethnic study support the concept that menstrual and reproductive factors, as well as the use of exogenous hormones, are associated with the risk of NAFLD.
Keywords: Birth Control; NASH; Steatosis; Worldwide.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Comment in
-
Epidemiologic Landscape of Nonalcoholic Fatty Liver Disease Is Changed During Lifetime by Menstrual and Reproductive Status and Sex Hormonal Factors.Clin Gastroenterol Hepatol. 2021 Jun;19(6):1114-1116. doi: 10.1016/j.cgh.2020.10.054. Epub 2020 Nov 3. Clin Gastroenterol Hepatol. 2021. PMID: 33157317 No abstract available.
-
Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women.Clin Gastroenterol Hepatol. 2022 Aug;20(8):1887-1888. doi: 10.1016/j.cgh.2021.09.006. Epub 2021 Sep 10. Clin Gastroenterol Hepatol. 2022. PMID: 34509644 No abstract available.
References
-
- Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md). 2016;64(1):73–84. Epub 2015/12/29. - PubMed
-
- Lonardo A, Bellentani S, Argo CK, et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2015;47(12):997–1006. Epub 2015/10/12. - PubMed
-
- Lonardo A, Carani C, Carulli N, et al. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. Journal of hepatology. 2006;44(6):1196–207. Epub 2006/04/19. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
